Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia
Open Access
- 31 March 2007
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 13 (3), 355-365
- https://doi.org/10.1016/j.bbmt.2006.11.004
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Prognosis in transplant-eligible patients with agnogenic myeloid metaplasiaCancer, 2005
- Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaBlood, 2005
- Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosisBritish Journal of Haematology, 2005
- Allogeneic hematopoietic stem cell transplantation for myelofibrosisBlood, 2003
- Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndromeBlood, 2002
- Curative Therapy of Advanced Essential Thrombocythemia or Polycythemia Vera by Hemopoietic Stem Cell TransplantationLeukemia & Lymphoma, 2002
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Allogeneic bone marrow transplantation for agnogenic myeloid metaplasiaBritish Journal of Haematology, 1997
- Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]Blood, 1996
- Quantitation of Bone Marrow Reticulin—A Normal RangeAmerican Journal of Clinical Pathology, 1971